Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Which Healthcare ETF Is the Better Buy: VanEck's Pharma Fund PPH or iShares' Biotech Fund IBB?
Investors choosing between VanEck Pharmaceutical ETF (PPH +1.11%) and iShares Biotechnology ETF (IBB -0.44%) are weighing a concentrated, dividend-paying basket of drugmakers against a broader, more volatile portfolio of biotech innovators. The…
Which Healthcare ETF Is the Better Buy: State Street's Pharma Fund XPH or iShares' Biotech Fund IBB?
State Street SPDR S&P Pharmaceuticals ETF (XPH -0.28%) and iShares Biotechnology ETF (IBB -0.44%) both offer targeted healthcare exposure, but they differ significantly in sub-sector focus, asset size, and cost structure. Healthcare investors often…
'Not a single prescription': How pharma firms are 'moving' codeine cough syrup to Bengal border districts
Nearly two lakh bottles of codeine-based cough syrup seized in Balurghat have been destroyed, 65 people arrested and 44 cases registered in Dakshin Dinajpur since June. South Dinajpur Superintendent of Police Abhishek Gupta said the scale of sales…
13 of 68 industrial liquidation sales this fall are biotech or pharma equipment.
One of the auctions is called 'Pfizer #162'. The auction house labels it Sale #162. It covers bioreactors, chromatography systems and centrifuges at five locations, from Mansfield, Massachusetts to Bothell, Washington, and bidding ends on December…
Ascendis Pharma A/S (NASDAQ:ASND) Stock Has Consensus Price Target of $313.52
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) has received an average recommendation of 'Moderate Buy' from the twenty-one analysts that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a…
Telangana government urged to clear fee reimbursement dues of pharmacy colleges
The Telangana Pharmacy Colleges Managements Association, comprising 120 private colleges and 3 government colleges, with approximately 70,000 students, has urged the government to clear the fee reimbursement dues that are meagre compared to others.
Kura Oncology: JNJ's Bleximenib Is A Serious Threat, But Kura Still Has A Fighting Chance
Kura Oncology is a cautious Hold: my $6.75 valuation implies roughly 10% downside, balanced against an established market presence and combination potential. JNJ's bleximenib showed stronger remission and response-duration metrics, complicating…
Reuters NEXT New York 2026: Dates, Speakers, Lineup
Reuters has unveiled the speaker lineup for its annual Reuters NEXT leadership summit, set to return to New York for two days starting December 1, 2026. The invitation-only gathering is expected to bring together 600+ CEOs and global decision…
Which Healthcare ETF Is Best for the Long Term: State Street's XPH or Invesco's PBE?
The State Street SPDR S&P Pharmaceuticals ETF (XPH -0.28%) offers broader exposure and lower expenses, while the Invesco Biotechnology & Genome ETF (PBE -0.56%) provides a concentrated, higher-yielding strategy focused on biotech momentum.
Best Growth Stocks To Add to Your Watchlist - November 15th
Could Falling Yields Make REIT Stocks Worth a Second Look? Prologis, Teledyne Technologies, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies…
Paysign: 3 Key Takeaways for Long-Term Investors
On its third-quarter 2026 earnings call, held on Nov. 9, 2026, Paysign (PAYS +0.32%) announced a 43% year-over-year revenue increase to $30.8 million, driven by expansion in its pharmaceutical copay assistance business. The shift from transactional…
From pills to orbit: Boryung heir's bold space bet
Third-generation CEO Kim Jung-gyun targets space revenue by 2030 as he seeks to turn ambitious investments into a viable business When Boryung signed a research cooperation agreement with German aerospace agency DLR last month, the Korean drugmaker…
Teva Pharmaceutical Industries Ltd. $TEVA Stock Purchased by Migdal Insurance & Financial Holdings Ltd.
Migdal Insurance & Financial Holdings Ltd. increased its stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 1.3% during the third quarter, according to the company in its most recent disclosure with the SEC. The…
How the government's flagship PLI schemes are lagging in job creation
5 min read New Delhi Make us preferred source on Google Your feedback has been reported succesfully. Launched in March 2020, the NDA-government's flagship production-linked incentive scheme (PLI) achieved 76% of its investment target and 64% of its…
ST×NLB Cross-References: Former Capitol haunt named after a milk brand
SINGAPORE – This week's ST×NLB Crossword was co-constructed by NLB's John Choo and Sasha Tan, who are part of a team of 40 volunteers from both organisations. Our title clue for this week references the MAGNOLIA (18D) Snack Bar, the…
Receive a Daily briefing on Pharma Industry News
Get Started